Robotic Assisted Percutaneous Coronary Intervention: Initial Australian Experience
Heart, Lung and Circulation · 2024
DOI: 10.1016/j.hlc.2024.01.019 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Heart, Lung and Circulation, 2024. Verfasst von James Leung und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Liverpool Hospital, Sydney, NSW, Australia; South West Sydney Clinical School, University of NSW, Warwick Farm, Sydney, NSW…. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Robotic Surgical Procedures. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of New South Wales, Ingham Institute for Applied Medical Research, National Heart Foundation of Australia.
Abstract (Originalsprache)
BACKGROUND & AIM: Robotic-assisted percutaneous coronary intervention (R-PCI) has been increasingly performed overseas. Initial observations have demonstrated its clinical efficacy and safety with additional potential benefits of more accurate lesion assessment and stent deployment, with reduced radiation exposure to operators and patients. However, data from randomised controlled trials or clinical experience from Australia are lacking. METHODS: This was a single-centre experience of all patients undergoing R-PCI as part of the run-in phase for an upcoming randomised clinical trial (ACTRN12623000480684). All R-PCI procedures were performed using the CorPath GRX robot (Corindus Vascular Robotics, Waltham, Massachusetts, USA). Key inclusion criteria included patients with obstructive coronary disease requiring percutaneous coronary intervention. Major exclusion criteria included ST-elevation myocardial infarction, cardiogenic shock or lesions deemed unsuitable for R-PCI by the operator. Clinical success was defined as residual stenosis
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Liverpool Hospital, Sydney, NSW, Australia; South West Sydney Clinical School, University of NSW, Warwick Farm, Sydney, NSW, Australia. Electronic address: james.leung@health.nsw.gov.au.
- Department of Cardiology, Liverpool Hospital, Sydney, NSW, Australia; South West Sydney Clinical School, University of NSW, Warwick Farm, Sydney, NSW, Australia.
- Department of Cardiology, Campbelltown Hospital, Sydney, NSW, Australia.
- Department of Cardiology, Liverpool Hospital, Sydney, NSW, Australia.
Förderung
- University of New South Wales
- Ingham Institute for Applied Medical Research
- National Heart Foundation of Australia
Zitieren
APA
Leung, J., French, J., Xu, J., Kachwalla, H., Kaddapu, K., Badie, T., Mussap, C., Rajaratnam, R., Leung, D., Lo, S., & Juergens, C. (2024). Robotic Assisted Percutaneous Coronary Intervention: Initial Australian Experience. Heart, Lung and Circulation. https://doi.org/10.1016/j.hlc.2024.01.019
Vancouver
Leung J, French J, Xu J, Kachwalla H, Kaddapu K, Badie T, et al. Robotic Assisted Percutaneous Coronary Intervention: Initial Australian Experience. Heart, Lung and Circulation. 2024. doi:10.1016/j.hlc.2024.01.019
BibTeX
@article{Leung2024,
author = {Leung, James and French, John and Xu, James and Kachwalla, Hashim and Kaddapu, Krishna and Badie, Tamer and Mussap, Christian and Rajaratnam, Rohan and Leung, Dominic and Lo, Sidney and Juergens, Craig},
title = {Robotic Assisted Percutaneous Coronary Intervention: Initial Australian Experience},
journal = {Heart, Lung and Circulation},
year = {2024},
doi = {10.1016/j.hlc.2024.01.019}
}
EUVIMED